Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation.
Limited quarterly history available
Operating Margin needs at least three reported quarters before a meaningful chart is shown.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Avalyn Pharma Inc. Common Stock
Market Cap
$1.15B
Operating Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
Operating Margin
10.25%
TTM Avg
9.64%
3Y Avg
3.98%
5Y Avg
-5.39%
Market Cap
$1.16B
Operating Margin
-240.38%
TTM Avg
-171.82%
3Y Avg
-189.28%
5Y Avg
-240.55%
Market Cap
$1.14B
Operating Margin
-36.08%
TTM Avg
-28.70%
3Y Avg
-24.53%
5Y Avg
-15.51%
Market Cap
$1.14B
Operating Margin
14.18%
TTM Avg
9.30%
3Y Avg
5.28%
5Y Avg
4.02%
Market Cap
$1.17B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.13B
Operating Margin
15.66%
TTM Avg
23.78%
3Y Avg
24.92%
5Y Avg
19.79%
Market Cap
$1.11B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.15B | 0.00% | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 10.25% | 9.64% | 3.98% | -5.39% |
| Nektar Therapeutics (NKTR)vs › | $1.16B | -240.38% | -171.82% | -189.28% | -240.55% |
| OPKO Health, Inc. (OPK)vs › | $1.14B | -36.08% | -28.70% | -24.53% | -15.51% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 14.18% | 9.30% | 5.28% | 4.02% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 15.66% | 23.78% | 24.92% | 19.79% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| IRadimed Corporation (IRMD)vs › | $1.09B | 31.92% | 30.59% | 30.27% | 23.69% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
